Sort
16,300 grants matching “fatty liver disease”
Managing Atherosclerosis by Modulating HDL Function
$693,767M. Reza Ghadiri · Scripps Research Institute, The · R01 · FY2019 · HL
Managing Atherosclerosis by Modulating HDL Function
$693,767M. Reza Ghadiri · Scripps Research Institute, The · R01 · FY2020 · HL
Neuroimaging predictors of bariatric surgical outcomes
$693,629Pavlos Papasavas · Hartford Hospital · R01 · FY2022 · DK
Investigation of synergy between Rifampin and SQ109, a new anti-TB drug candidate
$693,529Venkata M Reddy · Sequella, Inc. · R21 · FY2009 · AI
The Role of Altered Luminal Dynamics in OSA-Induced Atherosclerosis
$693,249Amir Zarrinpar · University Of California, San Diego · R01 · FY2023 · HL
Targeting host lipid metabolism to limit tissue damage in necrotizing fasciitis
$693,175Steven J Bensinger · University Of California Los Angeles · R01 · FY2025 · AI
Exosomal biomarkers for the early detection of hepatocellular carcinoma
$693,134Ajay Goel · Beckman Research Institute/City Of Hope · R01 · FY2024 · CA
Animal Models for Studying the Genetics of Hypertension
$692,895Oliver Smithies · Univ Of North Carolina Chapel Hill · R01 · FY2007 · HL
Deep Phenotyping of Human Knockouts and Population Studies of the APOC3 Pathway
$692,812Daniel James Rader · University Of Pennsylvania · R01 · FY2019 · HL
Role of a Novel Hormone Complex, Fabkin, in Dyslipidemia and Inflammation in Atherosclerosis
$692,742Gokhan S Hotamisligil · Harvard University D/B/A Harvard School Of Public Health · R01 · FY2025 · HL
Searching the blood metabolome to identify risk biomarkers for biliary tract cancer
$692,641Wei Zheng · Vanderbilt University Medical Center · U01 · FY2022 · CA
LIPIDOMICS BASED DIAGNOSTICS FOR NONALCOHOLIC STEATOHEPATITIS
$692,611Arun J Sanyal · Virginia Commonwealth University · R01 · FY2016 · DK
HIV, HCV and the Menopausal Transition: Effects on Steatosis and Fibrosis Progression
$692,364Phyllis C Tien · Northern California Institute/Res/Edu · R01 · FY2017 · DK
Nutrient Overload, Insulin Resistance, and Hepatic Mitochondrial Dysfunction
$692,311Elizabeth Jane Parks · University Of Missouri-Columbia · R01 · FY2020 · DK
The interaction effects of genetic variants, age, diet, sex and mitochondrial copy number on Alzheimer's disease, aging-phenotypes and longevity
$692,124David George Ashbrook · University Of Tennessee Health Sci Ctr · R01 · FY2025 · AG
Control of cancer cachexia via stimulation of resolution of inflammation
$691,696Dipak Panigrahy · Beth Israel Deaconess Medical Center · R01 · FY2025 · CA
Nonalcoholic Fatty Liver Disease (NAFLD) in Polycystic Ovary Syndrome: The Role of Androgens on Liver Injury and NAFLD Progression
$691,653Monika Sarkar · University Of California, San Francisco · R01 · FY2025 · DK
Molecular mechanisms underlying the genetic association between PPP1R3B and hepatic steatosis
$691,510Daniel James Rader · University Of Pennsylvania · R01 · FY2020 · DK
Thyroid Hormone Receptors in Health and Disease
$691,214Sheue-Yann Cheng · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Them1-Mediated Metabolic Regulation and Pathogenic Role in MASLD
$690,943David E Cohen · Brigham And Women'S Hospital · R01 · FY2025 · DK
Them1-Mediated Metabolic Regulation and Pathogenic Role in NAFLD
$690,791David E Cohen · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · DK
Molecular Regulation of Muscle Glucose Metabolism in Man
$690,639Lawrence J Mandarino · University Of Arizona · R01 · FY2021 · DK
Molecular Regulation of Muscle Glucose Metabolism in Man
$690,639Lawrence J Mandarino · University Of Arizona · R01 · FY2022 · DK
Glycemic and Weight Loss Effects of Semaglutide in Subjects After Spinal Cord Injury and Type 2 Diabetes
$690,638Marzieh Salehi · University Of Texas Hlth Science Center · R01 · FY2024 · DK
Innate Immune Mechanisms Contributing to Cancer Growth in Obesity
$690,624Edgar G. Engleman · Stanford University · R01 · FY2024 · CA